North America’s medical devices industry saw a drop of 27.27% in cross border deal activity in Q3 2022
Led by SD Biosensor and SJL Partners’s $1.54bn private equity deal with Meridian Bioscience, North America’s medical devices industry saw…
Led by SD Biosensor and SJL Partners’s $1.54bn private equity deal with Meridian Bioscience, North America’s medical devices industry saw…
Total medical devices industry cross border venture financing deals worth $1.7bn were announced globally in Q3 2022, led by $223m…
Led by $3.12bn private equity deal with Evident, Asia-Pacific’s medical devices industry saw a drop of 32.82% in cross border…
Bain Capital’s $3.12bn private equity deal with Evident was the medical devices industry’s biggest cross border deal of Q3 2022…
Total medical devices industry cross border M&A deals worth $1.5bn were announced globally in Q3 2022, led by Azenta’s $468.22m…
Total medical devices industry cross border M&A deals worth $1.1bn were announced in Europe in Q3 2022, led by Azenta’s…
Led by $223m venture financing of Cleerly, total medical devices industry cross border venture financing deals worth $1.1bn were announced…
Led by $100m venture financing of Kerecis ehf, total medical devices industry cross border venture financing deals worth $298.3m were…
Total medical devices industry cross border deals worth $2.6bn were announced globally for November 2022, with WerfenLife’s $2bn acquisition deal…
Total medical devices industry cross border deals worth $4.5bn were announced globally for October 2022, with the $2.6bn acquisition of…